Regen Biopharma INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
OID
Quick Capital, LLC has reported a 9.9% beneficial ownership stake in Regen BioPharma, Inc.'s common stock, holding 3,320,000 shares.